Work

The use of tocilizumab to treat recurrent thyroid eye disease previously treated with teprotumumab

Year: 2024

Type: article

Abstract: The use of biologics in the treatment of corticosteroid-resistant thyroid eye disease has increased in popularity over the last several years. Here, we describe a patient with progression of symptoms despite multiple courses of corticosteroids, orbital decompression, and teprotumumab. The patient was successfully treated with tocilizumab and remains clinically stable 18 months status post treatment.

Source: Duke journal of case reports in ophthalmology.

DOI: 10.62856/djcro.v1i1.26

Author: Omi Pang

Institution: Michigan State University

Language: English

Topic: Ophthalmology and Eye Disorders

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4402472290

FWCI:

Cites:

Cited by:

Related to: 10